Saturday, January 10, 2026

In Detail Full day, Saturday, January 10, 2026, Timezone: America/Chicago

Pomelo Care banks $92M to expand virtual women's health, pediatric care services

fiercehealthcare - Pomelo Care banked $92 million in series C funding as it expands beyond maternity care to to more broadly serve women's and children's health needs.

AI Summary: In a bold move that underscores investor confidence, Pomelo Care has raised $92 million in a Series C round. The funding is set to power an expansion beyond maternity care into comprehensive virtual women’s and pediatric health services—proving that when it comes to disruptive healthcare innovation, sometimes the numbers do all the talking.

New US diet guidelines push whole foods, meat and dairy

medicalxpress - The federal government has released new dietary guidelines that shift how Americans are urged to eat.

AI Summary: The federal government has unveiled a major revision in its dietary guidelines—urging Americans to favor whole foods such as lean meats, dairy and protein sources while cutting ultraprocessed items. This unexpected pivot in nutritional policy is sparking conversations about what “healthy eating” will really mean moving forward.

21,000 New York nurses to launch strike Jan. 12

fiercehealthcare - Twelve private sector hospitals in New York City and three in Long Island could see nurses walk off the job if no new contract deal is reached. It would be the largest nurse strike in New York City's history.

AI Summary: Reports indicate that while a large contingent of New York nurses – reportedly 21,000 – was poised to strike on January 12, negotiations at seven hospitals have led to tentative agreements that cancelled the planned walkout. Conflicting reports highlight the volatile nature of labor actions in the region.

Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals

Frank Vinluan / medcitynews - Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments. In addition to its internal pipeline, Aktis has a discovery partnership with Eli Lilly. The post Akt…

AI Summary: Aktis Oncology’s debut on the public market raised $318M, buoyed by a 25% first‐day bounce. The IPO not only generated strong investor enthusiasm for biotech in 2026 but also signals the company’s ambitious plans to extend its portfolio of innovative miniprotein radioconjugates for targeted cancer therapy.